1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow ALTCAR.CD30 cells: new trials by email Literature Review of ALTCAR.CD30 cells trials Research Report on ALTCAR.CD30 cells
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL ATLCAR.CD30.CCR4 cells, ALTCAR.CD30 cells, Bendamustine - Lymphoma, Immune System Diseases | Phase 1 | Active not recruiting | UNC Lineberger Comprehensive Cancer Center | 43 | 2018-10-29 | 2026-06-12 |
Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, T-Cell, Cutaneous (1) · Lymphomatoid Papulosis (1) · Lymphoproliferative Disorders (1) · Mycosis Fungoides (1) · Neoplasms (1) · Sezary Syndrome (1)
UNC Lineberger Comprehensive Cancer Center (1)
United States (1)
R01CA247497 (1)